Altamira Therapeutics Ltd
CYTO
CYTO was delisted on the 19th of December, 2024.
10 hedge funds and large institutions have $41M invested in Altamira Therapeutics Ltd in 2015 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.
17% less funds holding
Funds holding: 12 → 10 (-2)
40% less capital invested
Capital invested by funds: $68.3M → $41M (-$27.4M)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
+$383K |
| 2 |
HCM
Harvey Capital Management
Palm Beach,
Florida
|
+$383K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CA
Cortland Advisers
Wilmington,
Delaware
|
-$7.73M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$2.3M |
| 3 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$1.11M |
| 4 |
CPCM
Clifton Park Capital Management
Wilmington,
Delaware
|
-$383K |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$383K |
CYTO Hedge Fund Activity: Q3 2015 in Review
10 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Altamira Therapeutics Ltd (CYTO) for Q3 2015, worth a combined $41M — down 40% from $68.3M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CYTO and 1 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 1 added.
The largest buyer was Alyeska Investment Group, adding an estimated $383K. The largest seller was Cortland Advisers, exiting entirely with an estimated $7.73M sold.
- 10 institutional investors held Altamira Therapeutics Ltd (CYTO) as of Q3 2015, down from 12 in Q2 2015.
- Funds reported $41M of Altamira Therapeutics Ltd stock for Q3 2015, down 40% quarter-over-quarter.
- 1 fund opened new Altamira Therapeutics Ltd positions in Q3 2015 and 3 closed out, a net change of -2 holders.
- The largest Altamira Therapeutics Ltd buyer in Q3 2015 was Alyeska Investment Group, an estimated $383K added.
- The largest Altamira Therapeutics Ltd seller in Q3 2015 was Cortland Advisers, an estimated $7.73M sold.
Based on aggregated 13F filings for Q3 2015.